Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Sponsor

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Posted

96

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Please log in to like, share and comment!

Nepali peacekeepers return from UN mission in Abyei

KATHMANDU: The third contingent of Nepali peacekeepers deployed under the United Nations Interim...

By 0 6

Covid-19: With 11 deaths, current wave toll in country past 100-mark

By 0 7

Middle East crisis: Donald Trump to leave G7 summit early over Iran-Israel conflict; warns Tehran to evacuate 'immediately'

Amid escalating tensions between Israel and Iran, US President Donald Trump will depart the G7...

By 0 21

Fortify the provincial structure for political stability

Nepal currently has a coalition government of major political parties like the Nepali Congress...

By 0 22

Supreme Court lawyer body slams ED notice to senior advocate

By 0 22